SAN DIEGO, June 02, 2025 -- BioAtla, Inc. (Nasdaq: BCAB) (the “Company”), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the...
Art Pappas will participate on a panel titled "Beyond Emerging Managers: Becoming an Established Manager" at the Emerging Managers 2009 Conference in Miami, FL
News | 04. 28. 2009
© 2025 Pappas Capital, LLC. ALL RIGHTS RESERVED.